Yes, but that's dependent upon the FDA looking favorably on isolating the Australian site data and not the trial as a whole. Again I'm definitely optimistic about this happening but there is still a small risk.
There's also no guarantee the Purisys supply won't come with similar or other issues as they are not a supplier that has been used before.
Also, I thought they had already begun the AD phase 2 trial but it sounds like they haven't yet? Will they be using Purisys for AD phase 2?
Comparing BTX1503 with its competitors, page-6
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.5¢ |
Change
-0.005(1.43%) |
Mkt cap ! $627.0M | |||
| Open | High | Low | Value | Volume |
| 35.0¢ | 36.0¢ | 34.5¢ | $1.255M | 3.601M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 206282 | 34.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.0¢ | 316320 | 5 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| BOT (ASX) Chart |